US Stocks
/
Neuropace, Inc. Share Price

Neuropace, Inc. Share Price

NASDAQ: NPCE | Small Cap
$14.79
+$0.80 (5.76%) Last updated on 08 Aug, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Neuropace, Inc. Stock Performance

Open
$13.85
Prev. Close
$13.98
Circuit Range
N/A
Day Range
$13.85 - $14.82
Year Range
$7.87 - $19.57
Volume
9,784
Average Traded
$14.28

Neuropace, Inc. Share Price Today

As of 10 August 2026, Neuropace, Inc.'s share price is $14.79. The stock opened at $13.85, compared to its previous close of $13.98. During today's trading session, Neuropace, Inc.'s share price traded between $13.85 and $14.82, with an average price of $14.34. Over the past 52 weeks, the stock has recorded a high of $19.57 and a low of $7.87. In terms of performance, Neuropace, Inc.'s share price has risen by 1.79% over the last six months and is up 61.64% on a year-on-year basis.

Neuropace, Inc. Share Price Chart

$13.85$14.82
L
Show Current Price
H

Neuropace, Inc. Stock Fundamentals & Key Indicators

Market Cap
$483.96M
PE Ratio (TTM)
-22.41
Dividend Yield
N/A
EPS (TTM)
$-0.66
Revenue (TTM)
$99.99M
Return On Equity (TTM)
-112.79%
Profit Margin
-21.47%
Debt to Equity
0.94
Quarterly Earnings Growth YoY
35.88%

Neuropace, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
Revenue$18.12M$19.26M$21.06M$22.52M$23.52M$27.35M
Net Profit-$8.93M-$7.51M-$5.45M-$6.59M-$8.65M-$3.50M
Net Profit Margin-49.24%-39.02%-25.89%-29.25%-36.78%-12.78%
Income ChangeN/A15.81%27.44%-20.85%-31.29%59.59%

Neuropace, Inc. Annual Profit & Loss

All figures in USD

Particulars20212022202320242025
Revenue$45.18M$45.52M$65.42M$79.91M$99.99M
Net Profit-$36.08M-$47.08M-$32.96M-$27.14M-$21.46M
Net Profit Margin-79.85%-103.43%-50.38%-33.97%-21.47%
Income ChangeN/A-30.49%30.00%17.64%20.91%

About Neuropace, Inc.

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet and patient data management system; and nSight Platform, which facilitates ongoing patient monitoring and streamlines patient support. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Neuropace, Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$13.22
$14.80
+15.31%
Jul 2026
$16.11
$12.84
-19.28%
Jun 2026
$16.25
$15.90
-3.40%
May 2026
$16.92
$16.46
-2.43%
Apr 2026
$13.66
$16.87
+28.39%
Mar 2026
$14.28
$13.14
-9.57%
Feb 2026
$15.38
$14.53
-3.97%
Jan 2026
$15.18
$15.13
-2.13%
Dec 2025
$16.33
$15.46
-5.47%
Nov 2025
$9.48
$16.36
+64.87%
Oct 2025
$9.96
$9.92
-3.78%
Sep 2025
$9.13
$10.31
+12.68%

NPCE Share Price FAQs

What is Neuropace, Inc. share price today?

chevron-up
Neuropace, Inc. share price today is $14.79 as on August 8, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Neuropace, Inc. stock?

chevron-up
The 52 week high of Neuropace, Inc. stock is $19.57, while the 52 week low is $7.87 as of 8 Aug '26.

What is NPCE's market capitalisation today?

chevron-up
NPCE market capitalisation is $483.96M as of August 10, 2026, at 9:25 am IST.

What is NPCE's net income for the last quarter?

chevron-up
NPCE's net income for the last quarter is -0.00B USD.

What is the 5 year returns of NPCE?

chevron-up
The 5 year returns of NPCE is -30.37% as on 8 Aug '26.

What is the high & low stock price of NPCE today?

chevron-up
NPCE stock price hit a high of $14.82 and low of $13.85 as of 8 Aug '26.

Can I buy NPCE shares in India?

chevron-up
Yes. You can buy NPCE in India by opening an international trading account.